Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases · 2025
[Immune-related colitis after immune checkpoint inhibitor rechallenging: a case report].
СтатьяКлинический случайАннотация на английскомНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Wang M Q, Shi Y J, Chen R X, Li Z Y, Xu K, Shao C, Huang H
Аннотация
Immune-related adverse events (irAE) are treatment-associated complications that single or multiple systems could be involved after immune checkpoint inhibitors(ICI), ranging from mild to life-threatening diseases, with significant heterogeneity. This is an important factor which might affect continuous ICI treatment. Patients who have experienced mild to moderate irAE could try ICI rechallenge after they recovered from irAE. However, patients would suffer from same or different irAE during ICI rechallenge. Our patient who was diagnosed with maxillary sinus carcinoma experienced checkpoint inhibitor pneumonitis (CIP) after anti-PD-1 therapy with combined chemotherapy and radiotherapy. Under closely follow-up, he tried same ICI rechallenge. Although he did not suffer from refractory CIP, he was diagnosed with immune-related colitis, which was recovered from ICI discontinuation and treatment of probiotics and Mesalazine.